cancer research

Unlike stopping a pathogen with an antibiotic or antiviral drug, a process that is simple and well-understood, getting a handle on the seemingly impossible complexity of cancer cannot be more different.

A company made grand pronouncements about revolutionizing cancer treatment claiming their discovery is so disruptive that, according to its

John LaMattina, the former head of R&D at Pfizer, tackles

Modern clinical research has turned to harnessing a patient s own immune system to block the proli